| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |